Navigation Links
PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans
Date:6/2/2009

nts had double lung transplants and seven patients had single lung transplants. Patients were given a single dose application of 10mg or 20mg of liposomal L-CsA, which was well tolerated. Deposition data showed a peripheral lung deposition of 2mg for a nominal, 10mg dose that was nebulized in less than ten minutes. Once daily administration of a nominal dose of 10mg L-CsA with an Investigational eFlow Nebulizer System would give approximately 14 mg L-CsA/week. Mean values for C(max) and AUC(0-inf) were up to 20ng/mL and 110 h ng/mL, respectively. These results are significantly lower compared to oral therapy. In comparison, oral CsA (Neoral(R)) therapy in lung transplant patients leads to highly variable C(max) and AUC(0-12h) values of approximately 1,800ng/mL and 8,000 h ng/mL, respectively when given twice daily in a dose of up to 250mg [Knoop 2003]. L-CsA's favorable and significantly lower pharmacokinetic values were obtained for both dose strengths tested. Phase Ib study results for L-CsA are published in the June 2009 volume of the Journal of Aerosol Medicine and Pulmonary Drug Delivery [Behr et al., Vol. 22, No. 2, p.121-129].

About PARI Pharma's Inhaled L-CsA Formulation

PARI Pharma's L-CsA is a low-dose, inhaled, liposomal cyclosporine A formulation that aims to improve the pharmacological profile, the highly variable bioavailability, and the severe side effects of oral CsA. (Severe side effects of oral CsA include kidney and brain damage, cancer, and vulnerability to infections.) L-CsA is an investigational, proprietary, liposomal formulation of 10mg CsA/2.5mL for inhalation delivery via a customized Investigational eFlow Nebulizer System. The L-CsA formulation is based on an artificial lung surfactant carrier. It is free of any irritating organic solvents and consists of unilamellar liposomes of about 100nm. The unilamellar liposomes are obtained via a high-pressure homogenization process using standard pharmaceutical
'/>"/>

SOURCE PARI Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
2. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
3. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
4. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
5. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
6. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
7. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
8. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
9. BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
10. Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
11. TRACON Pharmaceuticals Small Molecule TRC102 and Antibody TRC105 to be Presented at ASCO 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Germany , August 28, 2014 ... available free of charge for people from 40 to 65 ... next two decades. Using a traffic light color scheme, the ... at risk. The new "CAIDE Dementia Risk App ... developed in collaboration with Karolinska Institutet in Stockholm ...
(Date:8/28/2014)... , Aug. 28, 2014 Synthetic ... novel anti-infective biologic and drug candidates targeting specific ... FUJIFILM Diosynth Biotechnologies UK Limited (Fujifilm), announced today ... of cGMP manufacturing of SYN-004, Synthetic Biologics, proprietary ... Clostridium difficile ( C. difficile ) infections. ...
(Date:8/28/2014)... -- Today is the official launch of a newly ... and pharmaceutical organizations that will work together to help ... medication. The Coalition will initially focus its efforts on ... nonmedical use vary, a 2013 study at one large ... college students reported nonmedical use of prescription stimulant medication ...
Breaking Medicine Technology:CAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 2Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 3Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 4Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 2New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 3New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 4New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 5New Coalition Aims to Help Prevent Misuse, Abuse and Diversion of ADHD Medications 6
... Inc. (Nasdaq: CRDC ) today announced that ... Proximal Anastomosis System during on- and off-pump coronary artery ... secure connection, or anastomosis, between a vein graft and ... during CABG procedures and was first shipped to Japan ...
... PHILADELPHIA, Jan. 26, 2012  The IP & Science ... Brazil,s Institute for Applied Economic Research (IPEA). This ... Policies for Innovation, Regulation and Infrastructure (DISET) branch ... of products, including generic pharmaceutical intelligence and tools ...
Cached Medicine Technology:Cardica Achieves Key Milestone With Over 25,000 PAS-Port® Proximal Anastomosis Systems Deployed Worldwide 2Thomson Reuters Helps Brazil's Institute for Applied Economic Research Identify New Generic Drug Opportunities 2
(Date:8/28/2014)... 2014 Canadian Linen and Uniform Service, ... America, today announced the launch of its new Customer ... with Canadian Linen even easier and more convenient for ... account information online and better communicate with the company. ... ability to:, , Access, download and ...
(Date:8/28/2014)... After more than two years of designing ... to announce the opening of Houston’s Mirror Mirror Beauty ... Mirror Mirror Beauty Boutique offers premium aesthetic services in ... of Richmond and Drexel near Highland Village, Mirror Mirror ... technology in a private, easy to access location. Patients ...
(Date:8/28/2014)... 28, 2014 Clarity PSO , ... re-certified as a federal Patient Safety Organization (PSO) for ... for Healthcare Research and Quality (AHRQ). Clarity PSO will ... and services following the true intentions of the Patient ... ”We are proud and eager to continue our journey ...
(Date:8/28/2014)... 2014 CMMI (Center for Medicare and Medicaid ... care to address patient needs. What does it all mean? ... (with more provider accountability) and reduce the cost of care. ... in the care of a patient get a single payment ... distribute it. If it sounds complicated, that's because it is. ...
(Date:8/28/2014)... 28, 2014 On September 10, the ... Isaacs, the chairperson, president and CEO of Aduro BioTech, ... the Mesothelioma Experts live broadcast. The interview will ... mesothelioma expert nurse practitioner, Mary Hesdorffer, APRN . ... Aduro BioTech’s experimental therapy for malignant pleural mesothelioma, known ...
Breaking Medicine News(10 mins):Health News:Canadian Linen and Uniform Service Launches New Customer Portal 2Health News:Canadian Linen and Uniform Service Launches New Customer Portal 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Med-Certification.com Expects Industry "Hiccups" with New Models for Patient Care and Reimbursement 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 2Health News:New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma 3
... 6 Align Technology, Inc. (Nasdaq: ALGN ) ... speak at two upcoming financial conferences. Both presentations, as noted ... section of Align Technology,s website at http://investor.aligntech.com . An ... three months. , Conference: Bank ...
... M. D. Anderson Clinical Services Outside of Houston PHOENIX, ... University of Texas M. D. Anderson Cancer Center announced ... here. The initiative joins Arizona,s leading provider of health care ... their families with an unprecedented level of cancer care in ...
... Africa, May 6 The healthcare industry ... vast inequalities in access to care. The ... 85.0% of the population, yet accounts for ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )Public-private partnerships offer an innovative ...
... and wife Ellen honored for generous contribution to New York University ... ... -- Dr. Jan Linhart, D.D.S. and his wife, Ellen Linhart, have ... Education Program at Dr. Linhart’s alma mater. In honor of this ...
... largest hospital ship charity were honored with a humanitarian award at a ... ... May 6, 2009 -- The founders of the world,s largest hospital ship ... London last night. , , , , ,The annual Variety ...
... innovation is L-Tox, for advanced liver support. L-Tox was formulated to ... , ... Anaheim, California (PRWEB) May 6, 2009 - ... a stop product use directive on May 1, 2009. All consumers ...
Cached Medicine News:Health News:Align Technology Executives to Present at Upcoming Financial Conferences 2Health News:Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona 2Health News:Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona 3Health News:South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan 2Health News:South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan 3Health News:Manhattan Dentist Inducted Into The Sir Harold Acton Society 2Health News:Mercy Ships Founders Receive Humanitarian of the Year Award From Variety Club 2Health News:Mercy Ships Founders Receive Humanitarian of the Year Award From Variety Club 3Health News:Mercy Ships Founders Receive Humanitarian of the Year Award From Variety Club 4Health News:Max Muscle Sports Nutrition Offers Support for Hydroxycut Recall 2Health News:Max Muscle Sports Nutrition Offers Support for Hydroxycut Recall 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: